About Helios Hanseklinikum Stralsund
"Das Helios Hanseklinikum Stralsund ist ein Haus der Schwerpunktversorgung mit 19 Fachabteilungen. Pro Jahr werden über 60.000 Patienten ambulant und stationär behandelt. Insgesamt verfügt das Klinikum über 923 Betten, die voll- und teilstationär, ambulant und als tagesklinische Plätze genutzt werden. Das Hanseklinikum ist akademisches Lehrkrankenhaus der Universitätsmedizin Greifswald und beschäftigt mehr als 1.550 Mitarbeiterinnen und Mitarbeiter. Damit ist es das größte Unternehmen und Arbeitgeber der Hansestadt Stralsund."
Clinical Trials at Helios Hanseklinikum Stralsund
During the past decade, Helios Hanseklinikum Stralsund conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Helios Hanseklinikum Stralsund"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Helios Hanseklinikum Stralsund
According to Clinical.Site data, the most researched conditions in "Helios Hanseklinikum Stralsund" are
"Anemia" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Kidney Diseases" (1 trials) and "Kidney Failure, Chronic" (1 trials). Many other conditions were trialed in "Helios Hanseklinikum Stralsund" in a lesser frequency.
Clinical Trials Intervention Types at Helios Hanseklinikum Stralsund
Most popular intervention types in "Helios Hanseklinikum Stralsund" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "BI 1015550" (2 trials), "Placebo" (2 trials), "Bevacizumab" (1 trials), "Cisplatin" (1 trials) and "DYNEPO (epoetin delta)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Helios Hanseklinikum Stralsund
The vast majority of trials in "Helios Hanseklinikum Stralsund" are
4 trials for "All" genders.
Clinical Trials Status at Helios Hanseklinikum Stralsund
Currently, there are NaN active trials in "Helios Hanseklinikum Stralsund".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Helios Hanseklinikum Stralsund,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Helios Hanseklinikum Stralsund, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".